Pleuropulmonary Blastoma: a Clinicopathological Analysis

Background and objective Pleuropulmonary blastoma (PPB) is a rare malignant tumor with unique clinicopathological features. The aim of this study is to investigate the clinicopathological features, the diagnosis and differential diagnosis of pleuropulmonary blastoma. Methods Five cases of PPB were a...

Full description

Bibliographic Details
Main Authors: Jun GAO, Shangfu ZHANG, Shifeng WANG, Shigao CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2010-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2010.05.31&path[]=1497
_version_ 1818317226672914432
author Jun GAO
Shangfu ZHANG
Shifeng WANG
Shigao CHEN
author_facet Jun GAO
Shangfu ZHANG
Shifeng WANG
Shigao CHEN
author_sort Jun GAO
collection DOAJ
description Background and objective Pleuropulmonary blastoma (PPB) is a rare malignant tumor with unique clinicopathological features. The aim of this study is to investigate the clinicopathological features, the diagnosis and differential diagnosis of pleuropulmonary blastoma. Methods Five cases of PPB were analyzed by light microscopy, immunohistochemistry and their clinical data, and the relative literatures were reviewed. Results Five cases of patients suffered from PPB were aged from 21 to 47 months (mean 32.8 months). Most of the masses were located in the thoracic cavities and 4 cases accompanied with pleural effusions. Histologically, these tumors included 1 case of type I PPB which showed pure cystic architecture; 2 cases were type II PPB which showed cystic and solid masses accompanied with rhabdomyoblastic differentiation and nodules of cartilage; the other 2 cases were type III PPB and characterized by absolute solid masses with anaplastic undifferentiated sarcomatous components. Immunohistochemical studies showed that tumor cells were positive for Vimentin and some for Desmin and Myogenin, the nodules of cartilage were positive for S-100. The tumor cells were negative for PCK, EMA and CD99. Conclusion Pleuropulmonary blastoma is a rare and highly aggressive malignancy arising in the lung and pleural of infancy and early childhood. The type I, II and III PPB have unique clinicopathological features respectively. This kind of tumor should be distinguished from some benign and malignant diseases such as congenital cystic adenomatoid malformation (CCAM) and embryonal rhabdomyosarcoma.
first_indexed 2024-12-13T09:33:58Z
format Article
id doaj.art-adb29dd45633466d91dfc02feb036157
institution Directory Open Access Journal
issn 1009-3419
1999-6187
language zho
last_indexed 2024-12-13T09:33:58Z
publishDate 2010-05-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-adb29dd45633466d91dfc02feb0361572022-12-21T23:52:24ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872010-05-01135550553Pleuropulmonary Blastoma: a Clinicopathological AnalysisJun GAOShangfu ZHANGShifeng WANGShigao CHENBackground and objective Pleuropulmonary blastoma (PPB) is a rare malignant tumor with unique clinicopathological features. The aim of this study is to investigate the clinicopathological features, the diagnosis and differential diagnosis of pleuropulmonary blastoma. Methods Five cases of PPB were analyzed by light microscopy, immunohistochemistry and their clinical data, and the relative literatures were reviewed. Results Five cases of patients suffered from PPB were aged from 21 to 47 months (mean 32.8 months). Most of the masses were located in the thoracic cavities and 4 cases accompanied with pleural effusions. Histologically, these tumors included 1 case of type I PPB which showed pure cystic architecture; 2 cases were type II PPB which showed cystic and solid masses accompanied with rhabdomyoblastic differentiation and nodules of cartilage; the other 2 cases were type III PPB and characterized by absolute solid masses with anaplastic undifferentiated sarcomatous components. Immunohistochemical studies showed that tumor cells were positive for Vimentin and some for Desmin and Myogenin, the nodules of cartilage were positive for S-100. The tumor cells were negative for PCK, EMA and CD99. Conclusion Pleuropulmonary blastoma is a rare and highly aggressive malignancy arising in the lung and pleural of infancy and early childhood. The type I, II and III PPB have unique clinicopathological features respectively. This kind of tumor should be distinguished from some benign and malignant diseases such as congenital cystic adenomatoid malformation (CCAM) and embryonal rhabdomyosarcoma.http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2010.05.31&path[]=1497Pleuropulmonary blastomaImmunohistochemistryPathologic diagnosisDifferential diagnosis
spellingShingle Jun GAO
Shangfu ZHANG
Shifeng WANG
Shigao CHEN
Pleuropulmonary Blastoma: a Clinicopathological Analysis
Chinese Journal of Lung Cancer
Pleuropulmonary blastoma
Immunohistochemistry
Pathologic diagnosis
Differential diagnosis
title Pleuropulmonary Blastoma: a Clinicopathological Analysis
title_full Pleuropulmonary Blastoma: a Clinicopathological Analysis
title_fullStr Pleuropulmonary Blastoma: a Clinicopathological Analysis
title_full_unstemmed Pleuropulmonary Blastoma: a Clinicopathological Analysis
title_short Pleuropulmonary Blastoma: a Clinicopathological Analysis
title_sort pleuropulmonary blastoma a clinicopathological analysis
topic Pleuropulmonary blastoma
Immunohistochemistry
Pathologic diagnosis
Differential diagnosis
url http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2010.05.31&path[]=1497
work_keys_str_mv AT jungao pleuropulmonaryblastomaaclinicopathologicalanalysis
AT shangfuzhang pleuropulmonaryblastomaaclinicopathologicalanalysis
AT shifengwang pleuropulmonaryblastomaaclinicopathologicalanalysis
AT shigaochen pleuropulmonaryblastomaaclinicopathologicalanalysis